TUMOUR - INHIBITING ACTION OF 1,6 - Di - (2 - BROMOETHYL - AMINO) - 1,6 - DIDEOXY - D - MANNITOL DIHYDROBROMIDE [DBM (R13)]
1959

Tumor-Inhibiting Action of DBM

Sample size: 39 publication Evidence: moderate

Author Information

Author(s): J. Balo, G. Kendrey, J. Juhasz, I. Besznyak

Primary Institution: Medical University, Budapest

Hypothesis

The study investigates the effectiveness of a nitrogen mustard derivative, DBM, in inhibiting tumor growth in various animal models.

Conclusion

DBM was found to significantly inhibit tumor growth in several types of transplantable tumors with less toxicity compared to nitrogen mustard.

Supporting Evidence

  • DBM significantly prolonged survival time in rats with Guerin carcinoma compared to untreated controls.
  • DBM showed a marked inhibitory effect on various transplantable tumors including Yoshida sarcoma and Ehrlich carcinoma.
  • DBM was less toxic than nitrogen mustard, allowing for prolonged treatment without significant weight loss.

Takeaway

Scientists tested a new drug called DBM to see if it could help stop tumors from growing in sick animals, and it worked pretty well without making them too sick.

Methodology

The study involved testing 23 nitrogen mustard-sugar compounds on transplantable tumors in rats and mice, measuring growth inhibition and survival time.

Limitations

The study primarily involved animal models, which may not fully represent human responses.

Participant Demographics

Wistar strain rats and white mice were used in the experiments.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication